Literature DB >> 11326244

Aspirin resistance after coronary artery bypass grafting.

N Zimmermann1, P Kienzle, A A Weber, J Winter, E Gams, K Schrör, T Hohlfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11326244     DOI： 10.1067/mtc.2001.111416

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  14 in total

Review 1.  Indirect comparison meta-analysis of aspirin therapy after coronary surgery.

Authors:  Eric Lim; Ziad Ali; Ayyaz Ali; Tom Routledge; Lyn Edmonds; Douglas G Altman; Stephen Large
Journal:  BMJ       Date:  2003-12-06

Review 2.  Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease.

Authors:  Amgad N Makaryus
Journal:  Clin Cardiol       Date:  2006-04       Impact factor: 2.882

Review 3.  Aspirin Use Prior to Coronary Artery Bypass Grafting Surgery: a Systematic Review.

Authors:  Ayman Elbadawi; Marwan Saad; Ramez Nairooz
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

4.  Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  Tyler J Gluckman; Rhondalyn C McLean; Steven P Schulman; Thomas S Kickler; Edward P Shapiro; John V Conte; Kathleen W McNicholas; Jodi B Segal; Jeffrey J Rade
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

5.  Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639).

Authors:  Mate Petricevic; Tomislav Kopjar; Hrvoje Gasparovic; Davor Milicic; Lucija Svetina; Boris Zdilar; Marko Boban; Martina Zrno Mihaljevic; Bojan Biocina
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

6.  Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device.

Authors:  Jawaad Sheriff; Gaurav Girdhar; Wei-Che Chiu; Jolyon Jesty; Marvin J Slepian; Danny Bluestein
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

7.  Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery.

Authors:  Frantisek Bednar; Pavel Osmancik; Jan Hlavicka; Vera Jedlickova; Zoltan Paluch; Tomas Vanek
Journal:  J Thromb Thrombolysis       Date:  2008-05-01       Impact factor: 2.300

8.  Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.

Authors:  Kenichi A Tanaka; Vinod H Thourani; Willis H Williams; Peggy G Duke; Jerrold H Levy; Robert A Guyton; John D Puskas
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

9.  Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275].

Authors:  Eric Lim; Jacqueline Cornelissen; Tom Routledge; Ayyaz Ali; Stephen Kirtland; Linda Sharples; Kate Sheridan; Sarah Bellm; Helen Munday; Stephen Large
Journal:  BMC Med       Date:  2006-05-22       Impact factor: 8.775

10.  Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia.

Authors:  Alejandro Roman-Gonzalez; Carlos Andrés Naranjo; Walter D Cardona-Maya; Dionis Vallejo; Francisco Garcia; Cesar Franco; Leonor Alvarez; Luis Ignacio Tobón; Marta Ibeth López; Carolina Rua; Gabriel Bedoya; Ángela Cadavid; José Domingo Torres
Journal:  Stroke Res Treat       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.